HANGZHOU, Sept 25 (Bernama) — Prime Minister Datuk Seri Anwar Ibrahim's three-day working visit to Shanghai and Hangzhou, China, is not just a routine diplomatic trip, but rather a new benchmark for the continuation of strategic relations that strengthen cooperation in various fields between the two countries.
From Harlina Samson
HANGZHOU, Sept 24 (Bernama) -- The MADANI government is finalising follow-up measures to address the concerns of local micro, small and medium enterprises (MSMEs) affected by competition from foreign e-commerce platforms, said Prime Minister Datuk Seri Anwar Ibrahim.
From Harlina Samson
HANGZHOU, Sept 24 (Bernama) -- Malaysia has secured more than RM28 billion in potential investments following trade talks with major Chinese industry players, said Prime Minister Datuk Seri Anwar Ibrahim.
KUALA LUMPUR, Sept 24 (Bernama) -- ImmunoScape Pte Ltd, an A*STAR spin-out developing T-cell receptor (TCR)-based cancer immunotherapies, has appointed biotechnology industry veteran Peter Olagunju as chief executive officer (CEO) to guide its "Seed and Boost" platform towards clinical development.
SHANGHAI, Sept 23 (Bernama) -- A roundtable discussion with industry leaders from 21 leading Chinese companies here focused on various high-impact sectors, including semiconductors, artificial intelligence (AI) and robotics, as Malaysia explores high-value strategic investments, said Prime Minister Datuk Seri Anwar Ibrahim.
By Zufazlin Baharuddin
KUALA LUMPUR, Sept 18 (Bernama) -- Eighty women entrepreneurs, including 20 from overseas, will set up booths at the Malaysia International Halal Showcase (MIHAS) 2026 as part of the Women in Export (WiEX) initiative.
KUALA LUMPUR, Sept 17 (Bernama) -- QurCan Therapeutics (QurCan), a Toronto-based biotechnology company, has announced an exclusive research and collaboration agreement with Eli Lilly and Company (Lilly) for the treatment of diseases of the central nervous system (CNS) and peripheral nervous system (PNS).
KUALA LUMPUR, Sept 10 (Bernama) -- Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first viral vector contract development and manufacturing organisation (CDMO), has secured a licence to manufacture therapeutic goods (GMP licence) from the Therapeutic Goods Administration (TGA) for its Sydney facility.
KUALA LUMPUR, Aug 28 (Bernama) -- The enhanced BioNexus Status framework strengthens Malaysia’s position as a platform for growing biotechnology companies by expanding support and responding to the industry’s evolving needs.
